VivoSeq
Other

Psychological Distress

1

Pipeline Programs

5

Active Trials

2

Companies Involved

Psychological Distress is an early-stage landscape with 1 program across 2 companies. The most active players are COMPASS Pathways, Eli Lilly. 1 program is in Phase 3.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

19/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Approved
No programs

Trial Status

6

clinical trials

Not yet recruiting3 · 50%
Recruiting2 · 33%
Completed1 · 17%

Trial Activity

6 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)